{
    "id": "0370",
    "question": "A 15-year-old boy with poorly controlled asthma presents to the emergency room complaining of severe shortness of breath. His mother reports that he had trouble breathing soon after he started playing soccer with some friends and was unable to use his inhaler as it was empty. His family history is notable for emphysema in his paternal uncle and cirrhosis in his maternal grandfather. The child\u2019s temperature is 99.0\u00b0F (37.2\u00b0C), blood pressure is 130/90 mmHg, pulse is 130/min, respirations are 28/min, and oxygen saturation is 91% on room air. Physical examination demonstrates wheezing bilaterally in all lung fields. The child is started on supplemental oxygen and a nebulized bronchodilator. Which of the following is a downstream effect of this medication?",
    "options": {
        "A": "Decreased leukotriene activity",
        "B": "Activation of muscarinic receptors",
        "C": "Decreased phosphodiesterase activity",
        "D": "Increased adenylate cyclase activity"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to identify the type of medication administered to the child. The child is started on supplemental oxygen and a nebulized bronchodilator, which is a common treatment for acute asthma exacerbations. The most likely medication administered is a short-acting beta-2 agonist (SABA) such as albuterol, which is commonly used for quick relief of bronchospasm in asthma. SABAs work by stimulating beta-2 receptors in the airway smooth muscle, leading to relaxation of the airway muscles and increased airflow. This results in bronchodilation and relief of symptoms. Now, let's analyze the options: A. Decreased leukotriene activity - Leukotriene modifiers are a class of medications that target the cysteinyl leukotriene pathway, which is involved in inflammation and bronchospasm in asthma. However, this is not a direct downstream effect of SABAs. B. Activation of muscarinic receptors - Muscarinic receptors are targets of anticholinergic medications, which are not the primary mechanism of action of SABAs. C. Decreased phosphodiesterase activity - Phosphodiesterase inhibitors are a class of medications that increase levels of cyclic AMP (cAMP) in cells, leading to smooth muscle relaxation. While phosphodiesterase inhibitors can be used in asthma, they are not a downstream effect of SABAs. D. Increased adenylate cyclase activity - Adenylate cyclase is an enzyme that converts ATP to cyclic AMP (cAMP), which is a key second messenger in cellular signaling pathways. SABAs work by stimulating beta-2 receptors, which activate adenylate cyclase, leading to increased cAMP levels and smooth muscle relaxation. Therefore, increased adenylate cyclase activity is a downstream effect of SABA administration. The correct answer is D. Increased adenylate cyclase activity.\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 11.264908075332642
}